You're not logged in. Please log in to earn stock or Bitcoin rewards on your prescription purchase.
Kotaraxap
Kotaraxap is the generic version of a biologic medication used to treat moderate to severe asthma, chronic obstructive pulmonary disease (COPD), and chronic rhinosinusitis with nasal polyps. It belongs to the class of monoclonal antibodies that target specific pathways in the immune system to reduce inflammation. Kotaraxap helps manage symptoms such as airway inflammation, wheezing, and nasal congestion by blocking inflammatory proteins. It is typically prescribed for patients whose conditions are not adequately controlled by standard inhalers or other therapies.
Rx. Enter your prescription
How would you like to get your prescription? Select an option
Pharmacy pickup
Select from 35,000 pharmacies
Free two-day delivery
Coming soon!
Find a pharmacy near you. Enter your ZIP code
Are you a member? Sign up or log in.
Members have saved
$NaN
using our savings card for instant savings.
Don't pay full retail price and miss out on potential savings. Try it now—you have nothing to lose!
NaNM
worth of Satoshi has been rewarded to our members.
Everyone who signs up enjoys the benefits of earning FREE Bitcoin with every purchase.
How much Bitcoin can you earn with Kotaraxap ?
The potential for Bitcoin rewards to increase and appreciate in value is a possibility to consider, which may occur over time.
See the value of your savings today
Today's Value
1 Bitcoin = $NaN
Bitcoin (BTC)
...
USD
$NaN
Adjust Bitcoin's potential value to see how much it could be worth
Potential Value
1 Bitcoin =
Bitcoin (BTC)
...
USD
$NaN
Frequently Asked Questions
How long does it take for Kotaraxap to start working?
Most patients notice improvements in symptoms within the first 2-4 weeks of treatment, with maximum benefits usually seen after a few months of consistent use.
Can Kotaraxap be self-administered?
Yes, Kotaraxap can be self-administered via pre-filled syringes or auto-injectors after receiving proper training from a healthcare provider.
What should I do if I miss a dose of Kotaraxap?
If you miss a dose, take it as soon as possible. If it’s close to your next scheduled dose, skip the missed dose and continue with your regular schedule. Do not double up doses.
Can I take Kotaraxap if I’m pregnant?
Kotaraxap should only be used during pregnancy if the potential benefits outweigh the risks. Be sure to discuss the risks with your healthcare provider if you are pregnant or planning to become pregnant.
Are there any dietary restrictions while taking Kotaraxap?
There are no specific dietary restrictions with Kotaraxap. However, patients should maintain a healthy diet and avoid substances that may exacerbate their underlying conditions (such as allergens for asthma).
Comprehensive Drug Guide
How Does Kotaraxap Work?
Kotaraxap works by targeting and inhibiting specific cytokines (immune signaling proteins) that play a key role in inflammation, particularly in the airways and nasal passages. By blocking these inflammatory pathways, Kotaraxap helps reduce airway constriction, mucus production, and overall inflammation, leading to better breathing and fewer asthma or COPD flare-ups.
Common Dosages
- Pre-filled syringes or auto-injectors: 100 mg, 200 mg, 300 mg
Typical Dosing
- For severe asthma: The usual dose is 300 mg every 4 weeks, with the possibility of adjustments based on the patient’s response and condition severity.
- For chronic rhinosinusitis with nasal polyps: 200 mg every 2-4 weeks, depending on symptom severity and treatment response.
Typical Dosing
FDA Approved Indications
- Severe asthma with an eosinophilic phenotype
- Chronic obstructive pulmonary disease (COPD) with frequent exacerbations
- Chronic rhinosinusitis with nasal polyps in adults
Who Shouldn't Take Kotaraxap?
- Known hypersensitivity to Kotaraxap or any of its components
- Active or chronic infections, particularly parasitic infections or untreated tuberculosis
Advice From The Pharmacist
- Kotaraxap is administered via subcutaneous injection, either by a healthcare provider or at home with proper training.
- Before starting treatment, patients should be tested for any underlying infections, including tuberculosis.
- Keep the medication refrigerated, and allow it to reach room temperature before injecting.
- If you experience new or worsening symptoms like shortness of breath or allergic reactions, contact your healthcare provider immediately.
Side Effects of Kotaraxap
Common Side Effects
- Injection site reactions (redness, pain, swelling)
- Headache
- Sore throat
- Upper respiratory infections
Uncommon/Severe Side Effects
- Severe allergic reactions (anaphylaxis)
- Increased risk of parasitic infections
- Exacerbation of pre-existing infections, including tuberculosis
Risks and Warnings of Kotaraxap
- Infection Risk: Kotaraxap can suppress parts of the immune system, making patients more susceptible to infections. Patients should be monitored for signs of infection, particularly parasitic infections and tuberculosis.
- Hypersensitivity Reactions: Serious allergic reactions can occur, and treatment should be discontinued if symptoms like rash, swelling, or difficulty breathing arise.
- Eosinophilic Conditions: Some patients may develop eosinophilia (high levels of eosinophils, a type of white blood cell) after starting treatment. This should be monitored closely.
Interactions with Kotaraxap
Common Drug Interactions
- Live vaccines: Live vaccines should not be administered while on Kotaraxap, as the immune system may not respond adequately to the vaccine, or the patient may be at risk of infection.
- Immunosuppressive medications: Combining Kotaraxap with other immune-suppressing drugs may increase the risk of infection.
Alternatives to Kotaraxap
- Dupixent (dupilumab): A monoclonal antibody that targets a different inflammatory pathway, used for asthma, atopic dermatitis, and nasal polyps.
- Xolair (omalizumab): A biologic treatment for severe allergic asthma and chronic hives.
- Nucala (mepolizumab): An IL-5 inhibitor used for asthma with an eosinophilic phenotype.
- Fasenra (benralizumab): Another monoclonal antibody targeting IL-5 used for severe asthma.
